Spago Nanomedical AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-26.55	-32.51	-42.22	-39.2	-39.07	Upgrade
Depreciation & Amortization	0.17	0.31	0.28	0.36	0.38	Upgrade
Other Operating Activities	-0.27	0.28	0.19	-	-	Upgrade
Change in Accounts Receivable	-	0.61	-3.58	-1.22	-0.54	Upgrade
Change in Other Net Operating Assets	-1.65	-3.35	0.42	1.87	3.67	Upgrade
Operating Cash Flow	-28.3	-34.67	-44.91	-38.19	-35.57	Upgrade
Capital Expenditures	-	-0.23	-0.15	-0.13	-0.37	Upgrade
Sale (Purchase) of Intangibles	-	-0	-0.35	-3.7	-4.25	Upgrade
Other Investing Activities	0.63	-	-	-	-	Upgrade
Investing Cash Flow	0.63	-0.23	-0.51	-3.83	-4.63	Upgrade
Issuance of Common Stock	25.07	24.7	30.86	58.42	69.15	Upgrade
Other Financing Activities	-0.2	-2.54	-2.33	-6.76	-4.94	Upgrade
Financing Cash Flow	24.87	22.15	28.53	51.66	64.21	Upgrade
Miscellaneous Cash Flow Adjustments	-	-0	0	-	-	Upgrade
Net Cash Flow	-2.8	-12.75	-16.88	9.64	24.01	Upgrade
Free Cash Flow	-28.3	-34.9	-45.06	-38.32	-35.94	Upgrade
Free Cash Flow Margin	-586.83%	-524.45%	-798.69%	-617.68%	-554.40%	Upgrade
Free Cash Flow Per Share	-0.07	-0.12	-0.46	-0.60	-0.91	Upgrade
Levered Free Cash Flow	-17.52	-25.82	-27.66	-27.13	-25.54	Upgrade
Unlevered Free Cash Flow	-17.52	-25.82	-27.66	-27.13	-25.54	Upgrade
Change in Working Capital	-1.65	-2.75	-3.16	0.65	3.13	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.